CEN Biotech Inc (CENBF)
0.0057
0.00 (0.00%)
USD |
OTCM |
Mar 28, 11:06
CEN Biotech Total Assets (Quarterly): 7.447M for March 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2023 | 7.447M |
December 31, 2022 | 7.859M |
September 30, 2022 | 7.912M |
June 30, 2022 | 8.074M |
March 31, 2022 | 8.325M |
December 31, 2021 | 8.441M |
September 30, 2021 | 8.402M |
June 30, 2021 | 6.150M |
March 31, 2021 | 6.214M |
December 31, 2020 | 6.314M |
September 30, 2020 | 6.558M |
June 30, 2020 | 6.971M |
March 31, 2020 | 7.155M |
December 31, 2019 | 7.296M |
September 30, 2019 | 7.379M |
June 30, 2019 | 7.477M |
Date | Value |
---|---|
March 31, 2019 | 7.520M |
December 31, 2018 | 7.315M |
September 30, 2018 | 9.084M |
June 30, 2018 | 8.961M |
March 31, 2018 | 9.394M |
December 31, 2017 | 9.021M |
September 30, 2017 | 4.595M |
June 30, 2017 | 4.506M |
March 31, 2017 | 4.628M |
December 31, 2016 | 8.430M |
September 30, 2016 | 8.828M |
June 30, 2016 | 8.613M |
March 31, 2016 | 8.292M |
December 31, 2015 | 8.295M |
September 30, 2015 | 8.463M |
December 31, 2014 | 8.456M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
6.150M
Minimum
Jun 2021
8.441M
Maximum
Dec 2021
7.382M
Average
7.447M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
Rimrock Gold Corp | 0.4013M |
InMed Pharmaceuticals Inc | 15.26M |
Venus Concept Inc | 98.92M |
Juva Life Inc | 19.95M |
Lucy Scientific Discovery Inc | 4.287M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 10.12M |
Shareholders Equity (Quarterly) | -2.672M |
Debt to Equity Ratio | -1.847 |
Current Ratio | 0.03 |
Net Debt Paydown Yield | 4.48% |